A Different Perspective on Evaluating the Malignancy Rate of the Non-Diagnostic Category of the Bethesda System for Reporting Thyroid Cytopathology: A Single Institute Experience and Review of the Literature.

Pembegul Gunes, Sule Canberk, Mine Onenerk, Murat Erkan, Nilufer Gursan, Emine Kilinc, Gamze Zeynep Kilicoglu
Author Information
  1. Pembegul Gunes: Department of Pathology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey.
  2. Sule Canberk: Department of Pathology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey.
  3. Mine Onenerk: Department of Pathology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey.
  4. Murat Erkan: Department of Pathology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey.
  5. Nilufer Gursan: Department of Pathology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey.
  6. Emine Kilinc: Department of Pathology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey.
  7. Gamze Zeynep Kilicoglu: Department of Interventional Radiology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey.

Abstract

OBJECTIVE: To determine the malignancy rate in the non-diagnostic (ND) category of the Bethesda System for Reporting Thyroid Cytopathology (BSRTC) based on a different approach in relation to histopathology diagnoses.
STUDY DESIGN: All ND fine needle aspirations (FNAs) that were performed under ultrasound guidance by an interventional radiologist with rapid on-site evaluation were included in the study. Slides were reevaluated to identify the cause of inadequacy as "qualitative" or "quantitative." The malignancy rate of the ND category was assessed. Nodule/patient characteristics were compared between benign and malignant cases within the study cohort.
RESULTS: The study cohort consisted of 192 ND aspirations. Overall there were 156 (81.3%) women and 36 (18.7%) men with a mean age of 50.6 years (range 24-82 years). The malignancy rate was 4.7%. None of the nodules (size, consistency, and number) or patient characteristics (gender and age) were found to be predictive of malignancy.
CONCLUSION: The malignancy rate of the ND category was high when compared to BSRTC predictions, but at the low end of the reported malignancy rates in the literature. Our results revealed that cyto-histopathologic correlation and method of malignancy rate estimation could have an effect on a wide range of reported malignancy rates. Furthermore, patient/nodule dependent factors were not statistically found to be predictive of malignancy.

References

  1. Am J Surg. 2008 Sep;196(3):398-402 [PMID: 18558398]
  2. World J Surg. 2012 Mar;36(3):586-92 [PMID: 22228400]
  3. Diagn Cytopathol. 2003 Oct;29(4):203-6 [PMID: 14506672]
  4. World J Surg. 2015 Jul;39(7):1721-7 [PMID: 25663015]
  5. Thyroid. 2009 Nov;19(11):1159-65 [PMID: 19888858]
  6. Cytopathology. 2011 Jun;22(3):164-73 [PMID: 20626438]
  7. Thyroid. 2015 Oct;25(10 ):1115-20 [PMID: 26148539]
  8. Am Surg. 1993 Jul;59(7):415-9 [PMID: 8323073]
  9. South Med J. 1997 Dec;90(12):1183-6 [PMID: 9404902]
  10. Acta Cytol. 1987 Sep-Oct;31(5):587-90 [PMID: 3673463]
  11. Ann R Coll Surg Engl. 2000 May;82(3):149-55 [PMID: 10858674]
  12. Cancer. 2007 Oct 25;111(5):306-15 [PMID: 17680588]
  13. Thyroid. 2001 Dec;11(12 ):1147-51 [PMID: 12186502]
  14. Am J Clin Pathol. 2011 May;135(5):750-2 [PMID: 21502429]
  15. Thyroid. 2001 Jun;11(6):581-9 [PMID: 11442006]
  16. Diagn Cytopathol. 2008 Jun;36(6):425-37 [PMID: 18478609]
  17. J Otolaryngol Head Neck Surg. 2015 Mar 12;44:12 [PMID: 25890284]
  18. Ann Surg Oncol. 2012 Jul;19(7):2304-9 [PMID: 22395996]
  19. Can Med Assoc J. 1976 Jul 3;115(1):35-40 [PMID: 1277058]
  20. Thyroid. 2016 Jan;26(1):1-133 [PMID: 26462967]
  21. Endocr Pathol. 2013 Jun;24(2):57-61 [PMID: 23512283]
  22. Ann Intern Med. 1993 Feb 15;118(4):282-9 [PMID: 8420446]
  23. Thyroid. 2010 Oct;20(10):1077-83 [PMID: 20883171]
  24. Diagn Cytopathol. 2015 Aug;43(8):622-8 [PMID: 25914194]
  25. Ann Surg Oncol. 2010 Aug;17 (8):2147-55 [PMID: 20217250]
  26. Arch Pathol Lab Med. 1989 Sep;113(9):1035-41 [PMID: 2774855]
  27. Acta Cytol. 1996 May-Jun;40(3):423-8 [PMID: 8669173]
  28. Diagn Cytopathol. 2012 May;40 Suppl 1:E27-32 [PMID: 22619156]
  29. PLoS One. 2012;7(11):e49078 [PMID: 23185295]

MeSH Term

Adult
Aged
Aged, 80 and over
Biopsy, Fine-Needle
False Negative Reactions
Female
Humans
Male
Middle Aged
Reproducibility of Results
Thyroid Gland
Thyroid Neoplasms
Thyroidectomy
Young Adult

Word Cloud

Created with Highcharts 10.0.0malignancyrateNDcategorystudyBethesdaSystemReportingThyroidBSRTCaspirationscharacteristicscomparedcohort7%ageyearsrangefoundpredictivereportedratesOBJECTIVE:determinenon-diagnosticCytopathologybaseddifferentapproachrelationhistopathologydiagnosesSTUDYDESIGN:fineneedleFNAsperformedultrasoundguidanceinterventionalradiologistrapidon-siteevaluationincludedSlidesreevaluatedidentifycauseinadequacy"qualitative""quantitative"assessedNodule/patientbenignmalignantcaseswithinRESULTS:consisted192Overall156813%women3618menmean50624-824NonenodulessizeconsistencynumberpatientgenderCONCLUSION:highpredictionslowendliteratureresultsrevealedcyto-histopathologiccorrelationmethodestimationeffectwideFurthermorepatient/noduledependentfactorsstatisticallyDifferentPerspectiveEvaluatingMalignancyRateNon-DiagnosticCategoryCytopathology:SingleInstituteExperienceReviewLiterature

Similar Articles

Cited By